FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018563352> ?p ?o ?g. }

• W2018563352 endingPage "767" @default.
• W2018563352 startingPage "759" @default.
• W2018563352 abstract "Direct comparison and ranking of vaccine formulations in pre-clinical studies will expedite the identification of cancer vaccines for clinical trials. Two human ErbB-2 (Her-2) vaccines, naked DNA and whole cell vaccine, were tested side-by-side in wild type and Her-2 transgenic mice. Both vaccines can induce humoral and cellular immunity to the entire repertoire of Her-2 epitopes. Mice were electro-vaccinated i.m. with a mixture of pGM-CSF and pE2TM, the latter encodes Her-2 extracellular and transmembrane domains. Alternatively, mice were injected i.p. with human ovarian cancer SKOV3 cells that have amplified Her-2. In wild type mice, comparable levels of Her-2 antibodies (Ab) were induced by these two vaccines. However, T cell immunity and protection against Her-2+ tumors were superior in DNA vaccinated mice. In BALB Her-2 transgenic (Tg) mice, which were tolerant to Her-2, DNA and cell vaccines were administered after regulatory T cells (Treg) were removed by anti-CD25 mAb. Again, comparable levels of Her-2 Ab were induced, but DNA vaccines rendered greater anti-tumor activity. In B6xDR3 Her-2 Tg mice that expressed the autoimmune prone HLA-DR3 allele, higher levels of Her-2 Ab were induced by SKOV3 cell than by Her-2 DNA. But anti-tumor activity was still more profound in DNA vaccinated mice. Therefore, Her-2 DNA vaccine induced greater anti-tumor immunity than cell vaccine, whether mice were tolerant to Her-2 or susceptible to autoimmunity. Through such side-by-side comparisons in appropriate pre-clinical test systems, the more effective vaccine formulations will emerge as candidates for clinical trials." @default.
• W2018563352 created "2016-06-24" @default.
• W2018563352 creator A5004417768 @default.
• W2018563352 creator A5017967471 @default.
• W2018563352 creator A5025165391 @default.
• W2018563352 creator A5059058405 @default.
• W2018563352 creator A5061700621 @default.
• W2018563352 creator A5077550472 @default.
• W2018563352 date "2008-10-03" @default.
• W2018563352 modified "2023-09-27" @default.
• W2018563352 title "Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity" @default.
• W2018563352 cites W1589813057 @default.
• W2018563352 cites W1590352003 @default.
• W2018563352 cites W1606090394 @default.
• W2018563352 cites W1621615533 @default.
• W2018563352 cites W1899637912 @default.
• W2018563352 cites W1949342640 @default.
• W2018563352 cites W1968243011 @default.
• W2018563352 cites W1982104320 @default.
• W2018563352 cites W1987992637 @default.
• W2018563352 cites W1988509089 @default.
• W2018563352 cites W1996259893 @default.
• W2018563352 cites W2013583584 @default.
• W2018563352 cites W2029075987 @default.
• W2018563352 cites W2031224312 @default.
• W2018563352 cites W2040935952 @default.
• W2018563352 cites W2046231107 @default.
• W2018563352 cites W2095156669 @default.
• W2018563352 cites W2101577390 @default.
• W2018563352 cites W2102508255 @default.
• W2018563352 cites W2108377768 @default.
• W2018563352 cites W2126065508 @default.
• W2018563352 cites W2128299880 @default.
• W2018563352 cites W2128964327 @default.
• W2018563352 cites W2129817669 @default.
• W2018563352 cites W2139126824 @default.
• W2018563352 cites W2141393790 @default.
• W2018563352 cites W2142294973 @default.
• W2018563352 cites W2144943759 @default.
• W2018563352 cites W2146384083 @default.
• W2018563352 cites W2161929126 @default.
• W2018563352 cites W2164486810 @default.
• W2018563352 cites W2186379414 @default.
• W2018563352 cites W2220402379 @default.
• W2018563352 cites W2394931631 @default.
• W2018563352 cites W4238492599 @default.
• W2018563352 cites W96814828 @default.
• W2018563352 doi "https://doi.org/10.1007/s00262-008-0599-x" @default.
• W2018563352 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3827718" @default.
• W2018563352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18836716" @default.
• W2018563352 hasPublicationYear "2008" @default.
• W2018563352 type Work @default.
• W2018563352 sameAs 2018563352 @default.
• W2018563352 citedByCount "18" @default.
• W2018563352 countsByYear W20185633522013 @default.
• W2018563352 countsByYear W20185633522014 @default.
• W2018563352 countsByYear W20185633522015 @default.
• W2018563352 countsByYear W20185633522016 @default.
• W2018563352 countsByYear W20185633522017 @default.
• W2018563352 countsByYear W20185633522020 @default.
• W2018563352 countsByYear W20185633522021 @default.
• W2018563352 crossrefType "journal-article" @default.
• W2018563352 hasAuthorship W2018563352A5004417768 @default.
• W2018563352 hasAuthorship W2018563352A5017967471 @default.
• W2018563352 hasAuthorship W2018563352A5025165391 @default.
• W2018563352 hasAuthorship W2018563352A5059058405 @default.
• W2018563352 hasAuthorship W2018563352A5061700621 @default.
• W2018563352 hasAuthorship W2018563352A5077550472 @default.
• W2018563352 hasBestOaLocation W20185633522 @default.
• W2018563352 hasConcept C153911025 @default.
• W2018563352 hasConcept C159047783 @default.
• W2018563352 hasConcept C159654299 @default.
• W2018563352 hasConcept C167508917 @default.
• W2018563352 hasConcept C195616568 @default.
• W2018563352 hasConcept C203014093 @default.
• W2018563352 hasConcept C2779341262 @default.
• W2018563352 hasConcept C2780801004 @default.
• W2018563352 hasConcept C2780868878 @default.
• W2018563352 hasConcept C86803240 @default.
• W2018563352 hasConcept C8891405 @default.
• W2018563352 hasConceptScore W2018563352C153911025 @default.
• W2018563352 hasConceptScore W2018563352C159047783 @default.
• W2018563352 hasConceptScore W2018563352C159654299 @default.
• W2018563352 hasConceptScore W2018563352C167508917 @default.
• W2018563352 hasConceptScore W2018563352C195616568 @default.
• W2018563352 hasConceptScore W2018563352C203014093 @default.
• W2018563352 hasConceptScore W2018563352C2779341262 @default.
• W2018563352 hasConceptScore W2018563352C2780801004 @default.
• W2018563352 hasConceptScore W2018563352C2780868878 @default.
• W2018563352 hasConceptScore W2018563352C86803240 @default.
• W2018563352 hasConceptScore W2018563352C8891405 @default.
• W2018563352 hasIssue "5" @default.
• W2018563352 hasLocation W20185633521 @default.
• W2018563352 hasLocation W20185633522 @default.
• W2018563352 hasLocation W20185633523 @default.
• W2018563352 hasLocation W20185633524 @default.
• W2018563352 hasOpenAccess W2018563352 @default.
• W2018563352 hasPrimaryLocation W20185633521 @default.

• next